Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Investigation
|
April 17, 2025
Disruption of Ataxia-telangiectasia mutated kinase enhances radiation therapy efficacy in spatially-directed diffuse midline glioma models
Avani Mangoli, Vennesa Valentine, Spencer Maingi, et al.
Neuro-Oncology Advances
|
October 16, 2023
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
Hao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, et al.
Scientific Reports
|
October 23, 2025
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8<sup>+</sup> infiltration in glioma
Kirit Singh, Matthew W Foster, Marlene J Violette, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Oncogenic drivers shape the tumor microenvironment in human gliomas
Bo Zhao, Chae Yun Cho, Lingqun Ye, et al.
Neuro-Oncology
|
May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition
Patricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
Shengnan Yu, Shiyou Wei, Milan Savani, et al.
Nature Medicine
|
February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
The Lancet. Oncology
|
October 3, 2024
A brave new framework for glioma drug development
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Cancer Immunology Research
|
April 4, 2024
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
Michael V Martin, Salvador Aguilar-Rosas, Katka Franke, et al.
Nature Communications
|
February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways
Mark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Investigation
|
April 17, 2025
Disruption of Ataxia-telangiectasia mutated kinase enhances radiation therapy efficacy in spatially-directed diffuse midline glioma models
Avani Mangoli, Vennesa Valentine, Spencer Maingi, et al.
Neuro-Oncology Advances
|
October 16, 2023
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
Hao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, et al.
Scientific Reports
|
October 23, 2025
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8<sup>+</sup> infiltration in glioma
Kirit Singh, Matthew W Foster, Marlene J Violette, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Oncogenic drivers shape the tumor microenvironment in human gliomas
Bo Zhao, Chae Yun Cho, Lingqun Ye, et al.
Neuro-Oncology
|
May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition
Patricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
Shengnan Yu, Shiyou Wei, Milan Savani, et al.
Nature Medicine
|
February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
The Lancet. Oncology
|
October 3, 2024
A brave new framework for glioma drug development
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Cancer Immunology Research
|
April 4, 2024
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
Michael V Martin, Salvador Aguilar-Rosas, Katka Franke, et al.
Nature Communications
|
February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways
Mark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Page
of 13